Biotech Values

[rfj1862]

RPRX

>I believe that increased T, back to normal or low normal, will qualify as a clinical endpoint in and of itself.<

Belief is good, but I would suggest you review the company's presentations before making that statement.


***Proud graduate of Columbia University: Valuing Academic Infighting, Inattentive Mentors, Indentured Graduate Students, and High Research Overhead***